Publications by authors named "Silvia Stocco"
and infections are associated with a broad clinical spectrum, ranging from asymptomatic cases to visceral leishmaniasis (VL) with high mortality rates. Clinical manifestations such as post-kala-azar dermal leishmaniasis (PKDL) and visceral leishmaniasis-associated hemophagocytic lymphohistiocytosis-mimic (VL-associated HLH-mimic) further contribute to the diversity of clinical manifestations. These clinical variations are intricately influenced by the complex interplay between the host's immune response and the parasite's escape mechanisms.
View Article and Find Full Text PDFArticle Synopsis
- Respiratory Syncytial Virus (RSV) is a leading cause of respiratory infections in young children, and the study aimed to explore how the SARS-CoV-2 pandemic affected RSV hospitalizations in kids.
- An analysis of children hospitalized for RSV from 2014 to 2023 revealed a significant increase in hospitalizations after the pandemic, particularly among older children, with 70% under one year old and many needing ICU care.
- Preventive strategies like Nirsevimab could have reduced hospitalizations by over 46%, and including older children with comorbidities could increase this prevention rate to more than 57%.